ENDRA Life Sciences (NDRA) Share-based Compensation Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Share-based Compensation Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.23% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.20% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 8.31% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 58.33% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 5.80% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -0.20% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 500.00% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 591.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 591.73% |
| Dec 31, 2025 | -98.06% |
| Sep 30, 2025 | 384.32% |
| Jun 30, 2025 | -78.81% |
| Mar 31, 2025 | -73.84% |
| Dec 31, 2024 | -58.22% |
| Sep 30, 2024 | -114.58% |
| Jun 30, 2024 | -27.07% |
| Mar 31, 2024 | 33.81% |
| Dec 31, 2023 | -13.83% |
| Sep 30, 2023 | -72.20% |
| Jun 30, 2023 | 188.67% |
| Mar 31, 2023 | -17.76% |
| Dec 31, 2022 | -29.38% |
| Sep 30, 2022 | 177.33% |
| Mar 31, 2022 | -10.38% |
| Dec 31, 2021 | -24.19% |
| Sep 30, 2021 | -34.72% |
| Mar 31, 2021 | -18.37% |
| Dec 31, 2020 | -44.31% |